Kiora Pharmaceuticals to Present Preclinical Data on KIO-104 for the Treatment of ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...